Why Smart MedTech Stalls in Procurement: Solving the Hospital Data Bottleneck

Sam: Did you know that 97% of hospital executives say privacy and security concerns are the main barrier stopping them from sharing health data with medtech companies?

Maya: That number really sets the stage for today's episode. We are unpacking a brand new report published by Accenture titled Scaling intelligent MedTech through data synchronization.

Sam: And before we dive into the deep end, a quick reminder that our voices are AI-generated, and this is a summary of a publicly available document.

Maya: Right. So, if you are a clinician on the wards, a hospital IT leader, or an executive at a medtech company, this document explains exactly why so many promising smart devices get stuck in pilot purgatory.

Sam: The core premise here is really fascinating. For decades, medtech companies competed on hardware. Who makes the best scalpel, the most reliable pacemaker, the sharpest imaging machine. But the report says that is over.

Maya: Exactly. Value is no longer bound by product performance. Intelligence is becoming the primary source of differentiation. Companies want to use data from connected devices for clinical decision support, measuring outcomes, and generating evidence.

Sam: Which sounds great in a pitch deck. But the report says the challenge is getting to scale, because the healthcare data ecosystem just wasn't built for this kind of smooth, coordinated exchange.

Maya: It really wasn't. And the authors outline four massive systemic barriers causing this friction. They call it a state of healthcare dissonance. And the first barrier is regulatory and legal uncertainty.

Sam: This brings us back to that 97% stat. Hospital executives are terrified of privacy breaches. And honestly, can you blame them?

Maya: You cannot. The report highlights that in 2025, a new annual record was set with 772 large healthcare data breaches reported to the US Department of Health and Human Services.

Sam: Wow. 772 in one year. That explains why nearly two-thirds of provider CXOs surveyed report rejecting data-sharing opportunities strictly due to security or compliance concerns.

Maya: For hospital leaders, regulation basically multiplies risk. They have to deal with HIPAA, state privacy laws, Institutional Review Boards, and internal governance. The CXOs surveyed emphasized that if shared data is misused, the reputational and regulatory consequences fall squarely on them.

Sam: So when a medtech company walks in and says they need data to train their new AI algorithm, the hospital's legal and security teams essentially form a brick wall.

Maya: Or worse, they form a maze. The report notes that these requests face such rigorous reviews that it causes delay and deprioritization. By the time a decision is finally made, priorities have shifted, and the opportunity just quietly expires.

Sam: It is a failure of the process, not the use case itself. And it is not just hospitals. Payers are equally terrified. They have to deal with Centers for Medicare and Medicaid Services interoperability rules, accreditation standards, and strict member contracts.

Maya: Yes, payer teams sequence these requests through legal, compliance, privacy, security, procurement, and actuarial reviews. And some Medicaid programs even prohibit data from residing outside the continental United States. So payers default to extended review cycles or narrowed approvals.

Sam: Which leaves the medtech companies totally stranded. The report surveyed 60 medtech executives, and 50% report difficulty accessing the data they need. And they need this data to survive.

Maya: They desperately need it. In fact, 89% of those medtech CXOs identify EMR/EHR and patient-level data as critical to their solutions. That is precisely the data that is most tightly regulated.

Sam: And the compliance burden is heavy. 95% of medtech CXOs cite regulatory and compliance hurdles as their biggest constraint, and 88% say lengthy compliance reviews pose the greatest challenge.

Maya: And if they are operating globally, it is even worse. Frameworks like the EU General Data Protection Regulation impose strict requirements on cross-border data transfers and secondary use. It turns what should be repeatable execution into a series of one-off efforts.

Sam: Okay, so regulation and privacy are barrier number one. What happens if you somehow get past the lawyers? You hit barrier number two, which is operational and technical alignment. Basically, the IT infrastructure.

Maya: This is where the boardroom meets the server room. The survey included 120 senior decision-makers at US healthcare provider organizations. And 89% of them cite integration challenges with legacy systems as a primary obstacle to data access.

Sam: Wait, really? 89%? I thought healthcare had made huge strides with cloud computing and modern interoperability standards over the last decade.

Maya: You would think so, but the reality on the ground is highly fragmented. 73% of providers actually say their IT infrastructure is not prepared, slightly prepared, or moderately prepared for future-ready interoperability.

Sam: So how does a medtech company usually discover this?

Maya: Usually the hard way. A medtech partner will assume that an EHR integration enables cross-department data flow. But then they find out that imaging, lab, and operational data are locked in totally separate systems with different interfaces and different owners.

Sam: So what looked like a simple API connection turns into a massive manual extraction project for the hospital's IT department.

Maya: Exactly. And provider IT teams are already lean and overstretched. The report quotes a CIO from a top 25 US health system saying, we are not fully interoperable, it takes a lot of work just to get systems talking to each other.

Sam: But what about standards like Fast Healthcare Interoperability Resources, or FHIR, and Health Level Seven? Aren't those supposed to fix this?

Maya: They exist, but they remain unevenly implemented across departments and facilities. Medicare follows those standards more consistently than commercial programs. The result is that medtech companies are pushed toward customized, site-specific integrations.

Sam: And the medtech execs feel this pain too, right? 91% of medtech CXOs cite EHR incompatibility as an issue.

Maya: Right. Even when standards exist, the integrations often require bespoke mapping. The hospital might have different EHR versions or different data configurations even within their own system.

Sam: So how is medtech responding with their checkbooks? The report looked at where they are investing over the next three years. 87% are investing in technical architecture, 63% in cybersecurity, and 62% in data and analytics capabilities.

Maya: But here is the catch. Those same CXOs expect the greatest growth impact to come from data and analytics at 67%, and interoperability at 57%.

Sam: Let me make sure I understand that. They are pouring money into building their own technical architecture, but they acknowledge that the actual growth will come from interoperability and data analytics?

Maya: Precisely. The report identifies this as a pattern of investing in technology build while underinvesting in the operating capabilities required to scale. It is a mismatch.

Sam: Which leads us perfectly into barrier number three: limited trust and partnerships. If the tech is hard, the human element might be even harder.

Maya: Quick note before we carry on. This spot is open for a sponsor. If your company builds or sells AI for healthcare and wants to reach the clinicians, health-system leaders and industry teams who listen to this show, the link to our sponsorship page is in the show notes.

Sam: And now, back to the document.

Maya: Trust is everything in healthcare. And right now, 61% of provider CXOs say they are willing to share data with medtech companies, but only 55% believe it will be used appropriately.

Sam: That is a pretty big trust gap. Although, it is worth noting they trust big tech even less. Big tech firms are only trusted by 20% of providers.

Maya: Medtech has a relative advantage because they are already embedded in clinical workflows. But it is not a free pass. Providers are okay sharing registry data or device-performance information, but they hesitate sharply on patient-level data because of fears around re-identification and downstream exposure.

Sam: And the medtech folks know they are under the microscope. Nearly 73% of medtech CXOs cite provider trust as a moderate to critical barrier.

Maya: Because they often discover way too late that what one hospital considers acceptable secondary use, another views as completely out of scope. If medtech cannot explain exactly how an AI model is being trained and safeguarded, providers just deny access.

Sam: This lack of trust is actually changing how medtech does business. The report has some wild numbers on how they are diversifying their partnerships. Over the next three years, their reliance on large health networks is only expected to grow a modest +11%.

Maya: But look at the alternatives they are flocking to. Collaborations with startups are expected to grow by +154%. Partnerships with regulatory bodies are up +128%, and third-party data aggregators are up +122%.

Sam: They are literally going around the hospitals. They are looking for intermediary-driven models because large provider systems have just become too hard to engage at scale.

Maya: Which is a tragic missed opportunity for clinical care. And that brings us to the fourth barrier, which might be the most fundamental one: value misalignment. They cannot agree on what success looks like.

Sam: Right, a medtech company views data as an input for innovation. But providers view themselves as stewards of that data, and they want reciprocal value. They want workflow relief.

Maya: Exactly. A medtech company might pitch a grand vision for population-level insights. But the clinical leader in the boardroom is asking: Which workflow improves? Which teams save time? What burden is removed?

Sam: There is a great quote here from a Chief Integration Officer at a top 20 US health system: They come with a view of 'we need all your data' and haven't thought through what they actually need.

Maya: That happens all the time. Providers want targeted pilots. They want to see automation that reduces nursing documentation time, or streamlines post-procedure monitoring. They do not want abstract promises.

Sam: And the payers have a totally different definition of value. They want to see measurable impacts on cost, quality metrics, and Star Ratings. If a digital solution doesn't support value-based care strategies, it loses momentum fast.

Maya: Medtech struggles to reconcile these competing expectations. And part of the problem is internal. According to the survey, only 23% of medtech CXOs report having a mature, enterprise-wide governance model.

Sam: So if the medtech company itself is fragmented internally, they cannot possibly deliver a coherent value story to the hospital or the payer.

Maya: Exactly. It creates external friction and weakens their ability to align around evidence generation and data reuse.

Sam: Okay, so we have four massive barriers: regulation, legacy IT, lack of trust, and mismatched value. It sounds pretty bleak. But the report outlines three specific levers medtech companies can pull to fix this. Let's walk through them.

Maya: The first lever is designing for predictability. Medtech companies need to stop treating every partnership as a custom, deal-by-deal negotiation. They need to set and enforce enterprise-wide positions on permissible data use, de-identification, and AI training.

Sam: The report notes there is a trade-off here. By setting a rigid standard, you might lose some flexibility in individual deals. But the payoff is faster deployment and fewer stalled pilots.

Maya: And this requires confronting that IT fragmentation head-on. Medtech needs to limit its tolerance for one-off integrations. They need to rely on reusable API layers and standards like FHIR and HL7.

Sam: The authors point to radiology as a massive success story for this. The Digital Imaging and Communications in Medicine standard, or DICOM, constrained variability. And because of that, scalable analytics are actually a reality in imaging.

Maya: Right, standardizing the core doesn't mean abandoning hospitals with legacy systems. It means binding that legacy integration so the complexity doesn't compound with every single new hospital you sign.

Sam: And there is real money on the table if they get this right. The report points out that shared savings programs in the US Medicare system generated record savings in 2024.

Maya: When you align the economics with the outcomes, you shift the conversation from price to partnership. Outcome-aligned commercial models produce measurable returns. But you cannot get there if your value proposition is vague.

Sam: Which leads to the third lever: institutionalizing execution across partnerships. Basically, making the collaboration repeatable.

Maya: Hospitals should experience a single, coherent posture from a medtech company, not fragmented conversations depending on which product line they are buying. This means using standardized legal agreements and recognized security frameworks like HITRUST.

Sam: It means having a clear pilot-to-scale pathway before the pilot even begins. You cannot just launch something and hope it scales later.

Maya: And interestingly, the report notes that not all medtech segments are in the same boat here. They have a maturity curve that dictates where companies should focus.

Sam: Right, I saw that chart. For example, surgical device companies are at an early stage. Only 29% of providers report secure integration with external partners in surgery.

Maya: So for surgical medtech, their immediate priority is that first lever: establishing basic regulatory and legal foundations just to make data exchange possible. They need standard master service agreements.

Sam: But if you look at imaging, it is way more mature. 67% of providers report secure integration in imaging. For them, it is less about basic access and more about value misalignment.

Maya: Exactly. For imaging and oncology, they need to focus on lever two. Sharpening those stakeholder-specific value propositions and tying their data access explicitly to measurable economic outcomes.

Sam: The authors warn that applying the wrong lever at the wrong stage just wastes capital. You do not want to build a sophisticated value-sharing framework if you do not even have standard terms and conditions in place.

Maya: This whole document is a wake-up call. Medtech's shift to AI is no longer a technology challenge. It is an operating model challenge. Leadership has to fund standardization over customization.

Sam: If they don't, the AI initiatives remain trapped in pilots, and the friction just keeps growing.

Maya: To recap today's deep dive: intelligent medtech is stalling because the ecosystem wasn't built for synchronized data exchange. Companies must standardize their regulatory postures, prove measurable workflow or financial value, and stop relying on bespoke IT integrations.

Sam: And remember to check the show notes for a link to the full Accenture report. Finally, as always, this podcast is for informational purposes only and is not medical advice. Thanks for listening.